GeoVax moves higher before the bell as traders watch for Mpox vaccine news
• GeoVax shares rallied in pre-market after closing Friday at $1.23.• The move follows last week’s Q1 update, with no new results from the clinic.• Cash burn, trial timelines and dilution remain key concerns. GeoVax Labs Inc. shares were up before the bell Monday, after the stock took a hit last week. The micro-cap vaccine company was shown at $2.34 by Benzinga at 6:45 a.m. EDT, then quoted at $2.61 on Public.com at 7:00 a.m. ET. GeoVax closed at $1.23. Pre-market action before 9:30 a.m. tends to be thin.
